These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35130080)

  • 1. Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience.
    Rosen GH; Nallani A; Muzzey C; Murray KS
    J Urol; 2022 Jun; 207(6):1302-1311. PubMed ID: 35130080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.
    Linehan J; Gottlieb J; Woldu SL; Labbate C; Rose K; Sexton W; Kaimakliotis H; Jacob J; Dickstein R; Nieder A; Bjurlin M; Humphreys M; Ghodoussipor S; Quek M; O'Donnell M; Eisner BH; Feldman AS; Matin SF; Lotan Y; Murray KS
    Eur Urol Focus; 2023 Nov; 9(6):1052-1058. PubMed ID: 37263827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.
    Labbate C; Woldu S; Murray K; Rose K; Sexton W; Tachibana I; Kaimakliotis H; Jacob J; Dickstein R; Linehan J; Nieder A; Bjurlin M; Humphreys M; Ghodoussipour S; Quek M; O'Donnell M; Eisner B; Feldman A; Lotan Y; Matin SF
    J Urol; 2023 May; 209(5):872-881. PubMed ID: 36657029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.
    Kaimakliotis HZ; Tachibana I; Woldu S; Labbate C; Jacob J; Murray K; Rose K; Sexton W; Dickstein R; Linehan J; Nieder A; Bjurlin M; Humphreys M; Ghodoussipour S; Quek M; O'Donnell M; Eisner BH; Matin SF; Lotan Y; Feldman AS
    Urol Oncol; 2023 Sep; 41(9):387.e1-387.e7. PubMed ID: 37246135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.
    Rose KM; Murray KS; Labbate C; Woldu S; Linehan J; Jacob J; Kaimakliotis H; Dickstein R; Feldman A; Matin SF; Lotan Y; Humphreys MR; Sexton WJ
    Eur Urol Focus; 2023 Sep; 9(5):807-812. PubMed ID: 37059620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.
    Woldu SL; Labbate C; Murray KS; Rose K; Sexton W; Tachibana I; Kaimakliotis H; Jacob J; Dickstein R; Linehan J; Nieder A; Bjurlin MA; Humphreys M; Ghodoussipour S; Quek ML; O'Donnell M; Eisner BH; Feldman AS; Matin SF; Lotan Y
    Urol Oncol; 2023 Mar; 41(3):147.e15-147.e21. PubMed ID: 36424224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
    Matin SF; Pierorazio PM; Kleinmann N; Gore JL; Shabsigh A; Hu B; Chamie K; Godoy G; Hubosky SG; Rivera M; O'Donnell M; Quek M; Raman JD; Knoedler JJ; Scherr D; Weight C; Weizer A; Woods M; Kaimakliotis H; Smith AB; Linehan J; Coleman J; Humphreys MR; Pak R; Lifshitz D; Verni M; Klein I; Konorty M; Strauss-Ayali D; Hakim G; Seltzer E; Schoenberg M; Lerner SP
    J Urol; 2022 Apr; 207(4):779-788. PubMed ID: 34915741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort study.
    Rose KM; Narang G; Rosen G; Labatte C; Dumitrascu CI; Campagna J; Yu A; Manley BJ; Spiess PE; Li R; Adibi M; Murray KS; Sexton WJ; Humphreys MR
    BJU Int; 2023 Apr; 131(4):471-476. PubMed ID: 36285629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
    Kleinmann N; Matin SF; Pierorazio PM; Gore JL; Shabsigh A; Hu B; Chamie K; Godoy G; Hubosky S; Rivera M; O'Donnell M; Quek M; Raman JD; Knoedler JJ; Scherr D; Stern J; Weight C; Weizer A; Woods M; Kaimakliotis H; Smith AB; Linehan J; Coleman J; Humphreys MR; Pak R; Lifshitz D; Verni M; Adibi M; Amin MB; Seltzer E; Klein I; Konorty M; Strauss-Ayali D; Hakim G; Schoenberg M; Lerner SP
    Lancet Oncol; 2020 Jun; 21(6):776-785. PubMed ID: 32631491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma.
    Shabsigh A; Kleinmann N; Smith AB; Scherr D; Seltzer E; Schoenberg M; Lerner SP
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):799-805. PubMed ID: 33677615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
    Chevli KK; Shore ND; Trainer A; Smith AB; Saltzstein D; Ehrlich Y; Raman JD; Friedman B; D'Anna R; Morris D; Hu B; Tyson M; Sankin A; Kates M; Linehan J; Scherr D; Kester S; Verni M; Chamie K; Karsh L; Cinman A; Meads A; Lahiri S; Malinowski M; Gabai N; Raju S; Schoenberg M; Seltzer E; Huang WC
    J Urol; 2022 Jan; 207(1):61-69. PubMed ID: 34433303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis.
    Laukhtina E; Kawada T; Quhal F; Yanagisawa T; Rajwa P; von Deimling M; Pallauf M; Bianchi A; Majdoub M; Enikeev D; Fajkovic H; Teoh JY; Rouprêt M; Gontero P; Shariat SF
    Eur Urol Focus; 2023 Mar; 9(2):258-263. PubMed ID: 36428210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
    Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
    J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.
    Jacob JM; Woldu SL; Linehan J; Labbate C; Rose KM; Sexton WJ; Tachibana I; Kaimakliotis H; Nieder A; Bjurlin MA; Humphreys M; Ghodoussipour SB; Quek ML; Johnson B; O'Donnell M; Eisner BH; Feldman AS; Murray KS; Matin SF; Lotan Y; Dickstein RJ
    Urol Oncol; 2024 Jan; 42(1):20.e17-20.e23. PubMed ID: 37517898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    Thalmann GN; Markwalder R; Walter B; Studer UE
    J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas.
    Porta C; Giannatempo P; Rizzo M; Lucarelli G; Ditonno P; Battaglia M
    Expert Opin Pharmacother; 2020 Dec; 21(18):2199-2204. PubMed ID: 32870051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.
    Eastham JA; Huffman JL
    J Urol; 1993 Aug; 150(2 Pt 1):324-5. PubMed ID: 8326553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Single-Dose Upper Urinary Tract Instillation of Mitomycin C After Therapeutic Ureteroscopy for Upper Tract Urothelial Carcinoma: A Single-Centre Prospective Non-Randomized Trial.
    Gallioli A; Boissier R; Territo A; Vila Reyes H; Sanguedolce F; Gaya JM; Regis F; Subiela JD; Palou J; Breda A
    J Endourol; 2020 May; 34(5):573-580. PubMed ID: 32164441
    [No Abstract]   [Full Text] [Related]  

  • 20. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
    Grasso M; Fishman AI; Cohen J; Alexander B
    BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.